首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinics and research in hepatology and gastroenterology

缩写:CLIN RES HEPATOL GAS

ISSN:2210-7401

e-ISSN:2210-741X

IF/分区:2.4/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引2449
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Julie Devictor,Anne Leclercq,Jean-Baptiste Hazo et al. Julie Devictor et al.
Hepatocellular carcinoma (HCC) mostly occurs in patients with chronic liver disease (CLD). HCC treatment may have a direct impact on CLD prognosis. HCC management can therefore become complex, involving multiple health care providers, such ...
Annemilaï Tijeras-Raballand,Marc Hilmi,Lucile Astorgues-Xerri et al. Annemilaï Tijeras-Raballand et al.
Pancreatic ductal adenocarcinoma (PDAC) incidence and related-deaths are increasing worldwide. PDAC is characterized by poor prognosis due to late diagnosis, high metastatic capacity and resistance to therapy. This is partially due to its s...
Dong Wu,Xiaoyin Bai,Peter Lee et al. Dong Wu et al.
Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently given to patients with acute pancreatitis (AP) for controlling pain, but their efficacy in treating AP, particularly in reducing systemic complicati...
Jean-Paul Cervoni,Blandine Alby-Lepresle,Delphine Weil et al. Jean-Paul Cervoni et al.
Background and aims: The reported hepatotoxicity of methotrexate underlines the need for a repeated non-invasive and reliable evaluation of liver fibrosis. We estimated, using a non-invasive strategy, the prevalence of si...
Yanying Gao,Hua Liu,Fei Tang et al. Yanying Gao et al.
Objective: To investigate the efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis (PVT). Methods: ...
Yuehuan Liu,Hongru Wu,Zhiyuan Wang et al. Yuehuan Liu et al.
Background: The morbidity of nonalcoholic fatty liver disease (NAFLD) has increased consistently in recent years. Exenatide could reverse liver fibrosis and lower the occurrence of fatty liver. The aim of the study was to...